 CAMBRIDGE, Mass., Nov. 04, 2021 GLOBE NEWSWIRE -- Relay Therapeutics, Inc. Nasdaq: RLAY, a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, plans to report third quarter 2021 financial results after the close of market on Wednesday, November 10, 2021. The company will not be conducting a teleconference in conjunction with its financial results press release. 